Reuters logo
BRIEF-FDA authorizes clinical trial for 22nd Century's Brand B cigarettes
May 1, 2017 / 11:24 AM / 7 months ago

BRIEF-FDA authorizes clinical trial for 22nd Century's Brand B cigarettes

May 1 (Reuters) - 22nd Century Group Inc

* FDA authorizes clinical trial for 22nd century’s Brand B low tar-to-nicotine ratio cigarettes

* 22nd Century Group Inc - 22nd Century’s proprietary Brand B cigarettes will be a modified-risk-tobacco-product candidate

* 22nd Century Group Inc - intends to submit a modified risk tobacco product (MRTP) application to FDA for Brand B

* 22nd Century Group Inc - engaged a contract research organization to conduct Brand B trial this summer Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below